Date: September 19, 2022
This randomized controlled trial tested whether the Collaborative Assessment and Management of Suicidality (CAMS), delivered through a “next-day appointment” outpatient clinic, reduced suicidal thoughts and behaviors more effectively than treatment as usual (TAU) for adults discharged after a suicide-related hospitalization. One hundred fifty participants — all with at least one lifetime suicide attempt — were randomized to CAMS or TAU and followed for 12 months.
Authors: Comtois, K. A., Hendricks, K. E., DeCou, C. R., Chalker, S. A., Kerbrat, A. H., Crumlish, J., Huppert, T. K., & Jobes, D.
About the Author
David A. Jobes Ph.D. ABPP
David Jobes, PhD, ABPP, is the founder of CAMS-care, LLC. He began his career in 1987 in the Counseling Center of the Catholic University of America, where he developed a suicide risk assessment tool for college students that evolved into CAMS. Dr. Jobes is now a Professor of Psychology and Associate Director of Clinical Training at Catholic; he has trained thousands of mental health professionals in the United States and abroad in evidence-based assessment and treatment of suicide risk and the use of CAMS.